Literature DB >> 6251443

Purification of subcomponents Clq, Cl(-)r and Cl(-)s of the first component of complement from Cohn Fraction I by affinity chromatography.

D H Bing, J M Andrews, K M Morris, E Cole, V Irish.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6251443     DOI: 10.1080/10826068009412829

Source DB:  PubMed          Journal:  Prep Biochem        ISSN: 0032-7484


× No keyword cloud information.
  9 in total

1.  Occurrence of beta-hydroxylated asparagine residues in non-vitamin K-dependent proteins containing epidermal growth factor-like domains.

Authors:  C T Przysiecki; J E Staggers; H G Ramjit; D G Musson; A M Stern; C D Bennett; P A Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  Sulfation of tyrosine residues increases activity of the fourth component of complement.

Authors:  G L Hortin; T C Farries; J P Graham; J P Atkinson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

3.  Fibronectin binds to the C1q component of complement.

Authors:  D H Bing; S Almeda; H Isliker; J Lahav; R O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

4.  Molar absorptivity and A1%1cm values for proteins at selected wavelengths of the visible and ultraviolet regions. XXIV.

Authors:  D M Kirschenbaum
Journal:  Appl Biochem Biotechnol       Date:  1985-08       Impact factor: 2.926

5.  Elastase regulates the synthesis of its inhibitor, alpha 1-proteinase inhibitor, and exaggerates the defect in homozygous PiZZ alpha 1 PI deficiency.

Authors:  D H Perlmutter; J Travis; P I Punsal
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

6.  Complement biosynthesis by the human hepatoma-derived cell line HepG2.

Authors:  K M Morris; D P Aden; B B Knowles; H R Colten
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

7.  Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities.

Authors:  L R Shoemaker; S J Schurman; V H Donaldson; A E Davis
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

8.  Amelioration of immune complex-mediated glomerulonephritis by synthetic protease inhibitors.

Authors:  J C Jennette; R R Tidwell; J D Geratz; D H Bing; R J Falk
Journal:  Am J Pathol       Date:  1987-06       Impact factor: 4.307

9.  Serologic and pathologic studies of mice immunized with homologous fibronectin.

Authors:  J E Murphy-Ullrich; T D Oberley; D F Mosher
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.